Real-time enrollment status for this sickle cell disease clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:46 AM UTC
| NCT Number | NCT06439082 |
| Recruiting Status | Recruiting |
| Condition | Sickle Cell Disease |
| Phase | PHASE3 |
| Target Enrollment | 354 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | October 15, 2026 (Yesterday) |
As of October 16, 2026: Clinical trial NCT06439082 is currently recruiting participants. This phase3 study for sickle cell disease is actively seeking new participants at 17 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06439082 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06439082 was last updated Yesterday (October 15, 2026). HelloStudys verifies this status automatically.